SOURCE: SRI International

October 23, 2007 08:30 ET

John Sternlicht Joins SRI International's Shenandoah Valley, Virginia Leadership Team

MENLO PARK, CA--(Marketwire - October 23, 2007) - SRI International, an independent nonprofit research and development organization, today announced that John Sternlicht, J.D., C.Ec.D., has joined its Biosciences Division as senior director of Strategic Projects at SRI Shenandoah Valley. Sternlicht has joined SRI from the Virginia Economic Development Partnership (VEDP), where he served as general counsel and legislative director.

In his new role at SRI, Sternlicht will focus on operations as well as business development and marketing opportunities for SRI Shenandoah Valley. He will work closely with Krishna Kodukula, Ph.D., executive director of SRI Shenandoah Valley and head of SRI's new Center for Advanced Drug Research (CADRE) in Harrisonburg, Virginia.

"John was a significant contributor to the establishment of SRI Shenandoah Valley, and he brings valuable experience in government relations, trade development, and business recruitment," said Walter Moos, Ph.D., vice president, SRI Biosciences Division. "His experience will be a tremendous asset to SRI, and we are pleased to welcome him to the organization."

Prior to his work with VEDP, Sternlicht served as Virginia's Deputy Secretary of Commerce and Trade and Assistant Attorney General. Previously, he was an attorney at Graham & James. He received his B.S. in Foreign Service from the Georgetown University School of Foreign Service and his J.D. from the University of North Carolina School of Law. He has also received a Certification in Economic Development (C.Ec.D.) and is fluent in English, French, Spanish, and German.

About SRI's Biosciences Division

SRI International's Biosciences Division teams with pharmaceutical and biotechnology companies, academia, foundations, and government agencies to solve important problems in global health. SRI Biosciences conducts basic research, drug discovery, and drug development, including contract research. SRI has all of the resources necessary to take R&D programs from "idea to IND"™ -- from initial discovery to investigational new drug applications to start human clinical trials -- and specializes in cancer, immunology, infectious disease, and neuroscience research. To date, SRI has helped advance more than 100 drugs into clinical trials, including a number of its own discoveries, several of which have reached the market. SRI is also working at the nexus of science and technology to create new technology platforms for the next generation of drug discovery and development in areas such as diagnostics, drug delivery, medical devices, and systems biology.

About SRI International

Silicon Valley-based SRI International (www.sri.com) is one of the world's leading independent research and technology development organizations. Founded as Stanford Research Institute in 1946, SRI has been meeting the strategic needs of clients for more than 60 years. The nonprofit research institute performs client-sponsored research and development for government agencies, commercial businesses, and private foundations. In addition to conducting contract R&D, SRI licenses its technologies, forms strategic partnerships, and creates spin-off companies.

Contact Information